The generative AI in drug discovery market is expected to grow at a CAGR of __% from 2023 to 2032, driven by the increasing demand for novel drugs to treat diseases. Generative AI is a type of machine learning that can be used to create new data, such as new molecules, based on patterns learned from existing data.
Get Sample copy of this report - Generative AI in Drug Discovery Market
This makes it a powerful tool for drug discovery, as it can be used to generate new drug candidates that are more likely to be effective and safe than those that are discovered through traditional methods.
The market is segmented by technology, end-user, and region.
By Technology
- Machine learning
- Reinforcement learning
- Deep learning
- Molecular docking
- Quantum computing
The machine learning segment is expected to dominate the market during the forecast period, followed by reinforcement learning, deep learning, molecular docking, and quantum computing. Machine learning is the most mature technology in generative AI and is already being used by pharmaceutical companies to discover new drugs.
Reinforcement learning is a type of machine learning that can be used to train AI agents to learn how to behave in a certain way. This makes it a promising technology for drug discovery, as it can be used to train AI agents to design new molecules that are more likely to be effective.
Deep learning is a type of machine learning that uses artificial neural networks to learn from data. This makes it a powerful tool for drug discovery, as it can be used to learn complex patterns in data that would be difficult to learn with other machine learning techniques.
Molecular docking is a technique that can be used to predict the binding affinity of a molecule to a target protein. This makes it a valuable tool for drug discovery, as it can be used to identify molecules that are likely to interact with a target protein.
Quantum computing is a new technology that has the potential to revolutionize drug discovery. Quantum computers are much faster than traditional computers and can be used to simulate the behavior of molecules at a much higher level of detail. This makes them a promising tool for drug discovery, as they can be used to identify new drug candidates that would be difficult to discover with traditional methods.
By end-user
- pharmaceutical and biotechnology companies
- academic and research institutions
- contract research organizations (CROs)
- Other End-Users
the pharmaceutical and biotechnology companies segment is expected to dominate the market during the forecast period. This is because pharmaceutical and biotechnology companies are the major users of generative AI for drug discovery.
Academic and research institutions are also expected to contribute significantly to the market growth.
Contract research organizations (CROs) are used by pharmaceutical and biotechnology companies to outsource drug discovery activities. They are also expected to contribute to the market growth.
Know more about this report (Description, TOC and List of Tables and Figures) - Generative AI in Drug Discovery Market
The market is analyzed across key regions, including
- North America,
- Europe,
- Asia-Pacific,
- Latin America,
- and the Middle East & Africa.
North America: Holding the lion's share of the market, North America's dominance is attributed to its robust healthcare infrastructure, major pharmaceutical players, and substantial investments in AI technologies.
Europe: With increasing R&D activities and supportive governmental initiatives, Europe is emerging as a key player in harnessing Generative AI for drug discovery.
Asia-Pacific: This region's ascent is characterized by growing R&D endeavors and a proactive approach towards integrating AI in pharmaceutical research.
Latin America: While relatively nascent, Latin America is witnessing a gradual adoption of Generative AI, with the potential for significant growth.
Middle East & Africa: Exploring the integration of Generative AI, this region presents unique growth opportunities as it diversifies its pharmaceutical research landscape.
The generative AI in drug discovery market is a rapidly growing market with a lot of potential. The market is expected to be driven by the increasing demand for novel drugs to treat diseases. Generative AI is a powerful tool that can be used to discover new drug candidates more quickly and efficiently than traditional methods. The market is expected to witness significant growth in the coming years.
To access valuable insights within the ‘Generative AI in Drug Discovery Market’ report, please share your contact details and express your intent to procure the report. Our dedicated sales team will promptly connect with you to provide additional information on the purchasing process for the ‘Generative AI in Drug Discovery Market’ report (Single User License).
About Us:
Pragma Market Research is a dynamic market research and consulting firm with experienced analysts in various industries. Our industries of expertise include Medical Devices, Pharmaceuticals, Semiconductors, Machinery, Information and Communication Technology, Automobiles, Chemicals and Materials, Packaging, Food and Beverages, Specialty Chemicals, Fast Moving Consumer Goods, and more.
Related Topics:
- AI in Agriculture Market
- Edge AI Hardware market
- Artificial Intelligence (AI) Verticals Market
- AI robots market
Note:
-Custom research reports can be available upon request.
-If you wish to request a discount, please refer to the discount link on our website or send an email to [email protected].
Contact Us:
+1 425 230 0999
